Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats
Open Access
- 31 December 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (1), 303
- https://doi.org/10.3390/ijms21010303
Abstract
The accumulation of fibrillar amyloid β-protein (Aβ) in blood vessels of the brain, the condition known as cerebral amyloid angiopathy (CAA), is a common small vessel disease that promotes cognitive impairment and is strongly associated with Alzheimer’s disease. Presently, the clinical diagnosis of this condition relies on neuroimaging markers largely associated with cerebral macro/microbleeds. However, these are markers of late-stage disease detected after extensive cerebral vascular amyloid accumulation has become chronic. Recently, we generated a novel transgenic rat model of CAA (rTg-DI) that recapitulates multiple aspects of human CAA disease with the progressive accumulation of cerebral vascular amyloid, largely composed of Aβ40, and the consistent emergence of subsequent microbleeds. Here, we investigated the levels of Aβ40 in the cerebrospinal fluid (CSF) and plasma of rTg-DI rats as CAA progressed from inception to late stage disease. The levels of Aβ40 in CSF and plasma precipitously dropped at the early onset of CAA accumulation at three months of age and continued to decrease with the progression of disease. Notably, the reduction in CSF/plasma Aβ40 levels preceded the emergence of cerebral microbleeds, which first occurred at about six months of age, as detected by in vivo magnetic resonance imaging and histological staining of brain tissue. These findings support the concept that reduced CSF/plasma levels of Aβ40 could serve as a biomarker for early stage CAA disease prior to the onset of cerebral microbleeds for future therapeutic intervention.Funding Information
- National Institutes of Health (NS094201, AG053991)
- ZonMw (733050822)
This publication has 51 references indexed in Scilit:
- Cerebral amyloid angiopathy pathology and cognitive domains in older personsAnnals of Neurology, 2010
- 11 C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhageNeurology, 2010
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal FluidBiological Psychiatry, 2009
- Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathyAnnals of Neurology, 2009
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyNeurology, 2008
- Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular ModelsBrain Pathology, 2006
- Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosisNature Neuroscience, 2004
- LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ IsoformsNeuron, 2004
- Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein PrecursorJournal of Biological Chemistry, 2004
- Pathogenesis of cerebral amyloid angiopathyBrain Research Reviews, 2003